Inhibition of the mitogen activated protein kinase ERK1/2 amplifies ochratoxin A toxicity in the proximal tubule of the kidney

scientific article published in June 2003

Inhibition of the mitogen activated protein kinase ERK1/2 amplifies ochratoxin A toxicity in the proximal tubule of the kidney is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02942949
P698PubMed publication ID23604762

P2093author name stringM Gekle
C Sauvant
H Holzinger
P2860cites workMammalian MAP kinase signalling cascadesQ28204140
The role of mitogen-activated protein (MAP) kinase in breast cancerQ30308930
Drug uptake systems in liver and kidneyQ35137526
Ochratoxin A in human blood in relation to nephropathy in TunisiaQ39198684
Human ochratoxicosis and nephropathy in Egypt: a preliminary studyQ39567391
The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluationQ40834119
Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells.Q40950403
Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation.Q54147741
Requirement of Erk, but not JNK, for arsenite-induced cell transformationQ63561118
Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feedQ68790531
P433issue2
P304page(s)118-123
P577publication date2003-06-01
P1433published inMycotoxin ResearchQ27723662
P1476titleInhibition of the mitogen activated protein kinase ERK1/2 amplifies ochratoxin A toxicity in the proximal tubule of the kidney
P478volume19